Compounds > staurosporine aglycone
Page last updated: 2024-10-29

staurosporine aglycone and Colorectal Neoplasms

staurosporine aglycone has been researched along with Colorectal Neoplasms in 2 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazouffre, C1
Geyl, S1
Perraud, A2
Blondy, S1
Jauberteau, MO2
Mathonnet, M2
Verdier, M1
Akil, H1
Mélin, C1

Other Studies

2 other studies available for staurosporine aglycone and Colorectal Neoplasms

ArticleYear
Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:10

    Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Autopha

2017
Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Adaptor Proteins, Vesicular Transport; Apoptosis; Blotting, Western; Brain-Derived Neurotrophic Fact

2011